{
  "id": 20708536,
  "title": "Drug-resistant infections could kill 39 million people by 2050, WHO warns",
  "url": "https://urgent.news/2026/11/19/drug-resistant-infections-could-kill-39-million-people-by-2050-who",
  "topic": "world",
  "section": "World",
  "published": "2026-11-19T05:30:21.000Z",
  "source": {
    "name": "3News",
    "slug": "3news",
    "url": "https://3news.com/news/health/who-drug-resistance-39-million-deaths-25-years"
  },
  "original_language": "en",
  "account": "The World Health Organization (WHO) has issued a dire warning that drug-resistant infections could claim up to 39 million lives by 2050 unless immediate action is taken. This alarming forecast comes prior to the commencement of World AMR Awareness Week, which begins on November 18. The figures were released by WHO on November 16, highlighting the fact that national action plans addressing drug resistance have now been established in 173 countries, up from 79 in 2017. These plans are part of commitments outlined in a 2024 United Nations political declaration on antimicrobial resistance. However, only 22 percent of these countries report having both the financial resources and full implementation of their national AMR plans. Dr. Tedros Adhanom Ghebreyesus, WHO's Director-General, emphasized the critical importance of these plans, stating that an incomplete plan is of no use. Bacterial AMR is already responsible for over 4.7 million annual deaths, and if left unchecked, could cost the global economy more than $3.4 trillion per year, particularly impacting low- and middle-income nations. In 2023, about one in six laboratory-confirmed bacterial infections worldwide exhibited antibiotic resistance. The situation is further complicated by weak testing capabilities, with only 36 percent of countries possessing a national reference lab capable of testing for the bacteria and fungi on WHO's list, falling short of the 80 percent target by 2030. Additionally, only 63 percent of countries have guidelines for the appropriate use of antimicrobials, and half are able to monitor antibiotic usage and resistance levels. To address these gaps, WHO has launched two new tools under its AMR Diagnostic Initiative: a list of priority tests and standard lab methods for diagnosing bacterial and fungal infections. In Ghana, the Pharmaceutical Society of Ghana has been actively campaigning against antibiotic overuse. WHO's regional office for Africa reports that AMR was linked to 23,000 deaths in Ghana in 2021, 1,512 of which were among children under five. Ghana was the inaugural country in the region selected to pilot WHO's people-centered approach to AMR. The WHO is also expected to make a decision on regulating colistin, a last-resort antibiotic for humans, in early 2025, according to its research program TDR. A study conducted by TDR found that resistance to colistin had risen on Greater Accra pig farms in Ghana for eight of nine antibiotics tested between 2022 and 2024. This World AMR Awareness Week, which will run from November 18 to 24 under the theme \"One Health, one action: Prevent AMR now,\" aims to underscore the necessity of collaborative efforts to curb AMR now.",
  "summary": "WHO says only 22 per cent of countries have funded and fully implemented plans against drug resistance, which threatens 39 million deaths by 2050.",
  "key_points": [
    "Drug-resistant infections could kill 39 million by 2050, warns WHO",
    "173 countries have national AMR action plans, up from 79 in 2017",
    "Only 22% of these countries fully implement their AMR plans"
  ],
  "editors_take": "The massive gap between national policy commitments and actual financial implementation threatens to turn antimicrobial resistance into a global catastrophe that disproportionately impacts low- and middle-income nations.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}